Proopiomelanocortin Deficiency: Clinical Trials

3 trials for Proopiomelanocortin Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Proopiomelanocortin Deficiency: new trials by email Literature Review of Proopiomelanocortin Deficiency trials Research Report on Proopiomelanocortin Deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Genetic Identification of Obesity
Genetic testing via blood collection - Obesity, Childhood, Hyperphagia
Active not recruitingRolfs Consulting und Verwaltungs-GmbH (RCV)10002024-01-242025-09-29
Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity
Setmelanotide - Bardet-Biedl Syndrome, POMC Deficiency Obesity
Phase 3CompletedRhythm Pharmaceuticals, Inc.122022-03-082024-11-27
Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway
Setmelanotide 2 mg, Setmelanotide 2.5 mg, Setmelanotide 3 mg - Bardet-Biedl Syndrome, POMC Deficiency
Phase 3CompletedRhythm Pharmaceuticals, Inc.192021-12-212024-11-26

Narrower conditions

Bardet-Biedl Syndrome (3)  ·  Hyperphagia (2)  ·  Pediatric Obesity (2)  ·  Cognitive Dysfunction (1)  ·  Obesity (1)  ·  Polydactyly (1)  ·  Retinal Diseases (1)  ·  Syndactyly (1)

Broader conditions

Abnormalities, Multiple (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Ciliopathies (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Eye Diseases (3)  ·  Eye Diseases, Hereditary (3)  ·  Genetic Diseases, Inborn (3)  ·  Hypothalamic Diseases (3)  ·  Nervous System Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Retinitis Pigmentosa (3)  ·  Signs and Symptoms (3)  ·  Body Weight (2)

Interventions

setmelanotide (2)

Sponsors

Rhythm Pharmaceuticals, Inc. (2)  ·  Rolfs Consulting und Verwaltungs-GmbH (RCV) (1)

Countries

Germany (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Netherlands (1)  ·  Puerto Rico (1)  ·  Spain (1)

Top investigators

David Meeker, MD (2)  ·  Arndt Rolfs, PhD, MD (1)

Results publications

PMID 39549719